There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Eli Lilly continues to break new ground. Its famous weight loss medicine, Zepbound (tirzepatide), just became the first to earn approval from the Food and Drug Administration as a treatment for ...

In both trials, people taking either dose of Zepbound experienced a significant reduction in the number of apneas and hypopneas per hour, as measured by the apnea-hypopnea index (AHI). Apneas are ...

Mounjaro was approved by the Food and Drug Administration to serve as weight management drug in November 2023 under the brand name Zepbound ... start on a 2.5 mg-dose injection once per ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Weekend Writer-Reporter at ...

Eli Lilly’s weight loss drug Zepbound is no longer in short supply ... as it has received reports of patients giving themselves the incorrect dose of off-brand drugs. "These dosing errors ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...

(HealthDay News) — The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA). In a news ...